异柠檬酸脱氢酶
医学
胶质母细胞瘤
甲基化
肿瘤科
甲基转移酶
切除术
癌症研究
内科学
核医学
DNA
外科
酶
核磁共振
生物
物理
遗传学
作者
Hye Hyeon Moon,Doonyaporn Wongsawaeng,Ji Eun Park,Seo Young Park,Seunghee Baek,Young‐Hoon Kim,Sang Woo Song,Chang‐Ki Hong,Jeong Hoon Kim,Myung Hwan Lee,Yae Won Park,Sung Soo Ahn,Jeffrey M. Pollock,Ramon Barajas,Ho Sung Kim
出处
期刊:Radiology
[Radiological Society of North America]
日期:2025-05-01
卷期号:315 (2): e241393-e241393
被引量:6
标识
DOI:10.1148/radiol.241393
摘要
= .04). Time-dependent areas under the receiver operating characteristic curve ranged from 0.684 (95% CI: 0.623, 0.745) to 0.694 (95% CI: 0.631, 0.758) and from 0.610 (95% CI: 0.449, 0.771) to 0.678 (95% CI: 0.512, 0.844), with CIT sensitivity for GTR-NET at 70.7%-77.3% and 87.6%-87.9% and C-indexes of 0.65 and 0.63. Conclusion A GTR-NET-based survival model was developed and validated, demonstrating that GTR-NET is an independent prognostic marker for longer OS in IDH-wildtype glioblastoma. ClinicalTrials.gov identifier: NCT02619890 © RSNA, 2025
科研通智能强力驱动
Strongly Powered by AbleSci AI